Skip to content
ppharmaranks
Menu
Class IICompleted

Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Med… recall

FDA recall D-0570-2024 · initiated Jun 26, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jul 10, 2024How we research

Medisca Inc. recalled Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline p… in Jun 2024 — an FDA Class II recall (D-0570-2024) because CGMP Deviations and Presence of Particulate Matter: Glass.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

CGMP Deviations and Presence of Particulate Matter: Glass

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot #s: 202323/G, 202323/H, Exp. 07/31/2026

Quantity recalled: 113 bottles

Details

Product
Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 38779-3097-00.
Recalling company
Medisca Inc.
Classification
Class II
Status
Completed
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA and Canada
Initiated
Jun 26, 2024
FDA report date
Jul 10, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline p… recalled?
Medisca Inc. recalled Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline p… in Jun 2024 — an FDA Class II recall (D-0570-2024) because CGMP Deviations and Presence of Particulate Matter: Glass. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline p… recalled?
Per the FDA enforcement record, the reason for recall D-0570-2024 was: CGMP Deviations and Presence of Particulate Matter: Glass
Is a recalled Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline p… dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline p… are affected?
Distributed: Nationwide in the USA and Canada. The recall covers these lots — Lot #s: 202323/G, 202323/H, Exp. 07/31/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0570-2024.

Source: openFDA Drug Enforcement record D-0570-2024

← All drug recalls